CVS Health Raises FY2026 Adj EPS Guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 Est; FY2026 Revenue expected to be more than $414.000M vs
CVS Health (NYSE: CVS ) raises FY2026 Adj EPS guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 analyst estimate. FY2026 Revenue expected to be more than $414.000M vs $409.235B Est
Story updates
10:33:01 AM UTC
SquawkNews
CVS Health (NYSE: CVS ) raises FY2026 GAAP EPS guidance from $6.24-$6.44 to $6.84-$7.04 vs $6.12 analyst estimate..
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.